Wolverine Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Wolverine Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-96,924	Closed	-$4.55M	–	1823
2025 Q2	$4.55M	Buy	+96,924	New	+$4.31M	0.04%	350

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Asset Management's SWTX Position: Q3 2025 in Review

Wolverine Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 96,924 shares — an estimated $4.55M sold.

Wolverine Asset Management first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $4.55M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Wolverine Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Wolverine Asset Management sold 96,924 SpringWorks Therapeutics shares in Q3 2025, an estimated $4.55M.
Wolverine Asset Management first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Wolverine Asset Management's SpringWorks Therapeutics position peaked at $4.55M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.